Skip to main content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Children in Child Welfare are More Likely to be Prescribed Psychotropic Medication than Other Children on Medicaid: Findings from Florida and Kentucky

Publication Date
Authors
Emily Madden, Marissa Abbott, Alex Adams and Cody Inman

The use of psychotropic medications in children is a complex issue for parents, caregivers, health care professionals, researchers, and policymakers. Psychotropic medications are used to treat behavioral health conditions. When these medications are prescribed appropriately, they can be effective in managing behavioral health symptoms. This brief looks at psychotropic prescribing patterns for children in the child welfare system and on Medicaid in two states. Key findings include:

  • Children on Medicaid and involved with the child welfare system were more likely to be prescribed psychotropic medications in comparison to children just on Medicaid. Using data from Kentucky and Florida, this includes both psychotropics overall and specifically for antidepressant, antipsychotic, and stimulant prescriptions.
  • Children ages 12 to 17 across the sample had a higher percentage of psychotropic medication prescriptions relative to younger children, with boys receiving more prescriptions than girls.
  • Among children in foster care, those placed in congregate care facilities or group homes were more likely to be prescribed a psychotropic medication than children in family foster homes. Children in non-relative family foster homes were more likely to be prescribed a psychotropic medication than children in relative family foster homes.

*This content is in the process of Section 508 review. If you need immediate assistance accessing this content, please submit a request to Robin Ghertner, Robin.Ghertner@hhs.gov. Content will be updated pending the outcome of the Section 508 review.

Product Type
Research Brief
Populations
Children | Families with Children | High-Need, High-Cost Populations